2 completed, 1 active not recruiting, 1 recruiting, 1 unknown. 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 2, Active not recruiting 1, Recruiting 1, Unknown 1 |
Follow Cancer of the Prostate: new trials by email Literature Review of Cancer of the Prostate trials Research Report on Cancer of the Prostate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve. Mevrometostat, Placebo, Enzalutamide - Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer | Phase 3 | Recruiting | Pfizer | 1000 | 2025-09-28 | 2026-10-14 |
| Fluciclovine (18F) PET/CT in biochemicAL reCurrence Of Prostate caNcer 18F-Fluciclovine PET CT - Cancer of the Prostate | Phase 3 | Completed | Blue Earth Diagnostics | 104 | 2015-11-01 | 2019-10-07 |
| Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK) Enzalutamide, Placebo (No longer applicable in Open Label study period), Leuprolide Open Label - Hormone Sensitive Prostate Cancer, Prostate Cancer | Phase 3 | Active not recruiting | Pfizer | 1068 | 2014-12-17 | 2026-10-26 |
| Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer Enzalutamide, Placebo - Nonmetastatic Castration-Resistant Prostate Cancer, Prostate Cancer | Phase 3 | Completed | Pfizer | 1401 | 2013-10-31 | 2026-01-27 |
| Multicentric Study Comparing Carcinological and Functional Results of Surgery Radical retropubic prostatectomy, Radical laparoscopy prostatectomy - Cancer of the PROSTATE | Phase 3 | Unknown | Assistance Publique - Hôpitaux de Paris | 1440 | 2007-12-01 | 2012-07-30 |
Genital Diseases (5) · Genital Diseases, Male (5) · Genital Neoplasms, Male (5) · Male Urogenital Diseases (5) · Neoplasms (5) · Neoplasms by Site (5) · Prostatic Diseases (5) · Urogenital Diseases (5) · Urogenital Neoplasms (5)
enzalutamide (3) · Leuprolide (1) · PF06821497 (1) · luprolide acetate gel depot (1)
Pfizer (3) · Assistance Publique - Hôpitaux de Paris (1) · Blue Earth Diagnostics (1)
France (4) · United Kingdom (4) · Australia (3) · Brazil (3) · Canada (3) · Finland (3) · Italy (3) · Netherlands (3) · Poland (3) · Slovakia (3) · South Korea (3) · Spain (3) · Taiwan (3) · United States (3) · Argentina (2)
PMID 29949494, PMID 30770294, PMID 31624865, PMID 32068113, PMID 32469184, PMID 33010985, PMID 34385241, PMID 34784577, PMID 35643841, PMID 35731340, PMID 36226865, PMID 36756959, PMID 37119051, PMID 37121865, PMID 37851874, PMID 38320501, PMID 38421243, PMID 38421252, PMID 40140551, PMID 40539499, PMID 41124201, PMID 41349040, PMID 41364813, PMID 41894648, PMID 42333826